Expression of the extracellular proteoglycan aggrecan is both cell-specific and developmentally regulated. Previous studies identified six functionally defined cis elements in the aggrecan promoter region which were shown to repress aggrecan gene expression (1). Using competition electrophoretic mobility shift assays (EMSAs) we have now identified in nuclear extracts a functional repressor cis element, (T/C)TCCCCT(A/C)RRC, which occurs at multiple locations within the chick aggrecan regulatory region. We purified the factor that binds to this cis element and established that it, APBP-1 (aggrecan promoter-binding protein-1), is a 19-kDa protein that has significant homology to CIRP (cold inducible RNA-binding protein). Recombinantly expressed APBP-1 mimics the native cis element-trans factor interaction in EMSAs. In situ hybridization demonstrates that aggrecan and APBP-1 RNA expression are restricted to complementary tissues in the developing limb, and Northern blot analysis of chick limb bud mRNA shows that APBP-1 mRNA expression is inversely correlated with aggrecan mRNA expression. Functional analyses by transient transfections and Northern blot analyses suggest APBP-1 has the capacity to repress aggrecan expression, indicating that this factor may be important regulator of aggrecan gene expression.Differentiation of mesenchymal cells to chondrocytes and elaboration by those cells of an extracellular matrix composed of aggrecan, link protein, and collagen types II, IX, and XI results in the highly specialized connective tissue cartilage, which exhibits unique biochemical and biomechanical properties. Coordinate regulation of the genes underlying these properties may be essential for normal skeletal development and subsequent maintenance of the cartilage phenotype in postnatal life (2).Eukaryotic gene regulation entails interplay between activators and repressors of transcription whose interactions influence the tissue-and developmental stage-specific expression of multitudes of genes. The aggrecan gene is dynamically regulated throughout embryonic life, with both mRNA and its protein product being up-regulated by 50-fold from day 2 to day 6, then undergoing a 2-fold decline by day 8 and reaching a steady plateau thereafter (2). Disruption of the delicate balance of transcription factors during development and/or later in life may lead to pathologic conditions. Although the etiologies of osteoarthritis and rheumatoid arthritis remain unknown, aggrecan degradation as well as reduced de novo matrix production is associated with each of these disease states.Therefore, to understand better how aggrecan gene expression is regulated, we have characterized the chick aggrecan gene promoter and enhancer region with the aim of identifying regulatory elements and their cognate transcription factors. We mapped a 400-bp region that actively mediates repression of aggrecan expression, removal of which increases aggrecan promoter activity by nearly 3-fold (3). Three DNase I-protected footprint sequences that mediate represso...